文献速递血栓与止血

免疫性血小板减少症患者血浆蛋白质组学的可行性

Feasibility of plasma proteomics in patients with immune thrombocytopenia.
PubMed 文献 · Br J Haematol · 2024-11-05

该述评讨论Jiang等对40例免疫性血小板减少症(ITP)患者、19例非ITP血小板减少患者和18例健康对照进行的血浆蛋白质组学研究,指出ITP患者具有独特的血浆蛋白质组学特征,但发现需进一步验证,血浆蛋白质组学在寻找ITP潜在生物标志物方面是可行且有前景的。

要点

  • ITP患者血浆蛋白质组学特征与非ITP血小板减少患者和健康人不同。
  • 血浆蛋白质组学在寻找ITP潜在生物标志物方面是可行且有前景的。
  • 上述发现需进一步验证和研究。

核心结论

  • ITP患者与非ITP血小板减少患者及健康个体相比具有独特的血浆蛋白质组学特征,血浆蛋白质组学在寻找ITP潜在生物标志物方面是可行且有前景的,但发现需进一步验证和研究。

研究设计与样本

  • Jiang等对40例ITP患者、19例非ITP血小板减少患者和18例健康对照进行血浆蛋白质组学检测。

主要发现

  • ITP患者血浆蛋白质组学特征与非ITP血小板减少患者和健康个体不同。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出上述发现需进一步验证和研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ITP is an acquired autoimmune bleeding disorder characterized by an isolated thrombocytopenia. The pathophysiology is highly multifactorial and involves antibody- and/or cytotoxic T cell-mediated killing of platelets and disruption of megakaryocyte function hampering platelet production. ITP remains a diagnosis of exclusion, and due to the high degree of variability between patients, it remains challenging to predict disease courses and responses to therapeutic agents. Hence, diagnostic and therapeutic laboratory biomarkers are highly warranted. To address this issue, in their paper, Jiang and colleagues have performed plasma proteomics in ITP patients (n = 40), in comparison to patients with thrombocytopenia due to other causes than ITP (non-ITP thrombocytopenia, n = 19) and healthy controls (n = 18). The data underscore that patients with ITP have a distinct plasma proteomic signature compared to non-ITP thrombocytopenia patients and healthy individuals. The findings should be further validated and investigated but suggest that the application of plasma proteomics is feasible and promising with respect to the search for potential biomarkers in patients with ITP. Commentary on: Jiang et al. Targeted proteomics profiling reveals valuable biomarkers in the diagnosis of primary immune thrombocytopenia. Br J Haematol 2025; 206:133-143.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Kapur R. Feasibility of plasma proteomics in patients with immune thrombocytopenia. Br J Haematol. 2024. PMID: 39497596. doi:10.1111/bjh.19882

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。